GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Current Ratio

BDMD (Baird Medical Investment Holdings) Current Ratio : 2.10 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Baird Medical Investment Holdings's current ratio for the quarter that ended in Jun. 2024 was 2.10.

Baird Medical Investment Holdings has a current ratio of 2.10. It generally indicates good short-term financial strength.

The historical rank and industry rank for Baird Medical Investment Holdings's Current Ratio or its related term are showing as below:

BDMD' s Current Ratio Range Over the Past 10 Years
Min: 2.1   Med: 2.11   Max: 2.2
Current: 2.1

During the past 3 years, Baird Medical Investment Holdings's highest Current Ratio was 2.20. The lowest was 2.10. And the median was 2.11.

BDMD's Current Ratio is ranked worse than
60.14% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 2.575 vs BDMD: 2.10

Baird Medical Investment Holdings Current Ratio Historical Data

The historical data trend for Baird Medical Investment Holdings's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Current Ratio Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23
Current Ratio
2.20 2.11 2.11

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
Current Ratio 2.20 2.11 - 2.11 2.10

Competitive Comparison of Baird Medical Investment Holdings's Current Ratio

For the Medical Devices subindustry, Baird Medical Investment Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baird Medical Investment Holdings's Current Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Current Ratio distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's Current Ratio falls into.


;
;

Baird Medical Investment Holdings Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Baird Medical Investment Holdings's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=40.083/18.975
=2.11

Baird Medical Investment Holdings's Current Ratio for the quarter that ended in Jun. 2024 is calculated as

Current Ratio (Q: Jun. 2024 )=Total Current Assets (Q: Jun. 2024 )/Total Current Liabilities (Q: Jun. 2024 )
=46.98/22.399
=2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baird Medical Investment Holdings  (NAS:BDMD) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Baird Medical Investment Holdings Current Ratio Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Baird Medical Investment Holdings Business Description

Traded in Other Exchanges
N/A
Address
No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN
Website
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.